| 105.734 0.492 (0.47%) | 12-10 14:40 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 123.65 | 1-year : | 123.74 |
| Resists | First : | 105.86 | Second : | 105.94 |
| Pivot price | 105.73 | |||
| Supports | First : | 105.73 | Second : | 87.97 |
| MAs | MA(5) : | 105.73 | MA(20) : | 105.73 |
| MA(100) : | 103.84  |
MA(250) : | 98.37 |
|
| MACD | MACD : | 0  |
Signal : | 0 |
| %K %D | K(14,3) : | 0 | D(3) : | 0 |
| RSI | RSI(14): 56.6 | |||
| 52-week | High : | 106.81 | Low : | 82.51 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ XDIV ] has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 34 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
The manager intends to replicate the returns of SPY through owning long positions in quarterly S&P 500 Index futures contracts traded on the CME rather than shares of SPY. Additionally, the manager intends to track the performance of the Metaurus Ex-Dividend Index by selling annual S&P 500 Dividend Futures Contracts out to the maturity date of the fund.
Thu, 28 Mar 2024
Sartorius Stedim Biotech (EPA:DIM) Stock Price Down 1.4% - Defense World
Thu, 28 Mar 2024
Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 (NYSEARCA:XDIV) Trading 0.5% Higher - Defense World
Mon, 15 Jul 2019
Metaurus Advisors is Granted Patent for the First-Ever Splitting of an Equity Index into Separate Components of ... - Business Wire
Tue, 20 Mar 2018
T. Rowe Price launches new multi-strategy total return fund - Financial Planning
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|